Your account is not claimed yet. You can sign up with ORCID to claim your account.

Alberto Garaventa

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Acute Lymphoblastic Leukemia

Diffuse Large B Cell Lymphoma

Mesenchymal Stem Cells

Top Venues

Cancer biology & therapy

Pediatric blood & cancer

Istituto Giannina Gaslini

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Giannina Gaslini

Italy

Head of Oncology Unit

Publications

Davide Massano, Elisa Carraro, Lara Mussolin, Salvatore Buffardi, Veronica Barat, Daniele Zama, Paola Muggeo, Francesca Vendemini, Antonella Sau, Maria Luisa Moleti, Federico Verzegnassi, Salvatore D'Amico, Tommaso Casini, Alberto Garaventa, Elisabetta Schiavello, Monica Cellini, Luciana Vinti, Piero Farruggia, Katia Perruccio, Simone Cesaro, Raffaela De Santis, Maddalena Marinoni, Irene D'Alba, Rosa Maria Mura, Roberta Burnelli, Maurizio Mascarin, Marta Pillon
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study. Pediatric blood & cancer 69 (10) (2022)
Marzia Ognibene, Martina Morini, Alberto Garaventa, Marina Podestà, Annalisa Pezzolo
Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients. Cancer biology & therapy 21 (5) (2020)
Fabio Morandi, Loredana Amoroso, Alessandra Dondero, Roberta Castriconi, Stefano Parodi, Roberto Luksch, Fiorina Casale, Aurora Castellano, Alberto Garaventa, Alessandro Moretta, Cristina Bottino, Mirco Ponzoni, Maria Valeria Corrias
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma. Oncoimmunology 7 (9) (2018)